Single-Cell Biology-

Decoding Spatial Multiomics with Harness, MCP, and API Keys to Connect 10x scRNA-seq Data

Single-cell biological data analysed with Claude, Gemini and GPT for scientific discovery

The single-cell biology combines biology, bioinformatics, mathematics, statistics, artificial intelligence and computing to explore biological systems at the scale of the individual cell. The increasing availability of data, particularly from the single-cell RNA sequencing (scRNA-seq) and spatial omics technologies opens new possibilities to study cellular heterogeneity, molecular interactions, and biological mechanisms.

Our platform explores how Claude, Gemini and GPT can be connected to modern methods of biological data analysis to support scientific exploration and interpretation. By combining artificial intelligence and computational biology, researchers can examine complex datasets, organise scientific information, explore biological relationships, and develop new data-driven discovery approaches.

The platform focuses on the intersection of single-cell biology, spatial multiomics, bioinformatics, and artificial intelligence. It presents the technologies and computational approaches that connect experimental data to their biological interpretation, from single-cell RNA sequencing and genomic analysis to the integration of spatial data and multi-omic research.

We explore how AI-assisted workflows can complement conventional computational methods and help researchers, students, and innovators in biotechnology navigate increasingly complex biological datasets. The aim is to link biological information to computational reasoning approaches and emerging artificial intelligence technologies, while promoting reproducible and research-oriented exploration.

Read the article

Bioinformatics • Genomics • Structural biology • AI in biology • Systems biology • Multi-omics • Molecular modelling

About single-cell sequencing, computational biology, and analysis by AI or superintelligence

The biology of single-cell sequencing is an interdisciplinary scientific field that focuses on the analysis of biological systems at the scale of individual cells using computational and data-driven approaches. The rapid growth of biological data generated by the next-generation sequencing (NGS), single-cell technologies, proteomics, transcriptomics, metabolomics, and advanced imaging has made computational analysis increasingly important in modern life sciences.

Today, biological research generates vast and complex datasets from DNA sequencing platforms, single-cell RNA sequencing, technologies of spatial omics, cryo-electron microscopy and mass spectrometry systems. The computational biology provides the algorithms, mathematical models, databases and machine learning approaches necessary to transform raw biological data into interpretable scientific information.

This field contributes to several scientific sectors, including:

Human genomics and personalised medicine
Cancer biology and biomarker discovery
Protein engineering and structural prediction
Evolutionary biology and phylogenetics
Drug discovery and molecular docking
Synthetic biology and metabolic engineering
Systems biology and network analysis
Precision diagnostics and therapeutic research
Microbiome analysis and environmental biotechnology

The computational biology plays an important role in studying diseases at the molecular and cellular level, analysing biological networks, predicting protein structures, identifying potential therapeutic targets, and developing biomedical technologies.

Key scientific areas

Multiomics, genomics and DNA analysis

The genomics involves studying the entire genetic material of organisms. Computational genomics allows for the analysis of complete genomes, gene expression profiles, genetic variations, and epigenetic modifications.

Modern sequencing technologies such as Illumina, Oxford Nanopore and PacBio generate vast genomic data sets requiring advanced computational pipelines for:

Genome assembly
Variant detection
SNP analysis
Comparative genomics
Functional annotation
Epigenomic profiling
CRISPR target analysis
Population genetics

The computational genomics contributes to the study of disease-associated mutations, cancer biomarkers, hereditary diseases, and potential therapeutic targets.

Spatial transcriptomics and RNA biology

The transcriptomics studies RNA expression profiles in cells, tissues, and different biological conditions. RNA sequencing (RNA-Seq) technologies allow for the quantification of gene expression and the study of cellular responses under physiological and pathological conditions. permettent de quantifier l’expression des gènes et d’étudier les réponses cellulaires dans des conditions physiologiques et pathologiques.

Computational transcriptomics includes, in particular:

Differential gene expression analysis
Single-cell RNA sequencing analysis
Alternative splicing analysis
Characterisation of non-coding RNAs — Learn more
Analysis of biological pathway enrichment
Modelling of gene regulatory networks
Analysis of cellular heterogeneity

The single-cell transcriptomics allows researchers to identify rare cell populations, study the dynamics of immune cells, characterise tumour heterogeneity, and investigate cellular states as well as developmental trajectories.

The spatial transcriptomics adds spatial information to molecular measurements, allowing the study of how gene expression profiles are organised within tissues.

Structural biology and protein modelling

Proteins are essential functional molecules that participate in almost all biological processes. Their biological activity is closely linked to their protéinesthree-dimensional structure, conformational flexibility, molecular interactions, and cellular environmentstructure tridimensionnelle, leur flexibilité conformationnelle, leurs interactions moléculaires et leur environnement cellulaire. Understanding protein structure is therefore fundamental for modern molecular biology, biotechnology, drug discovery, and protein engineering.

Computational structural biologybiologie structurale computationnelle combines the principles of molecular biology, biophysics, chemistry, mathematics, computer science, and artificial intelligence to study protein structures and molecular interactions. Computational approaches can help researchers predict protein conformations, analyse structural changes, identify interaction sites, and design new protein variants.

Prediction of protein structure

The prediction of protein structure aims to determine the three-dimensional organisation of a protein from its amino acid sequence or other available biological information.

Computational prediction can provide information on :

Protein folds
Secondary and tertiary structures
Structural domains
Functional regions
Potential binding sites
Conformational states

Modern approaches based on machine learning have significantly expanded the ability to generate structural models of proteins and protein complexes. These predictions can complement experimental techniques such as X-ray crystallography, nuclear magnetic resonance (NMR), and cryo-electron microscopy (cryo-EM).

Molecular docking

The molecular docking is a computational method used to study how two molecules can interact.

In structural biology, docking can be used to study :

Protein-ligand interactions
Protein-protein interactions
Protein-nucleic acid interactions
Potential binding sites
Molecular recognition
The relative orientations of bound molecules

Docking approaches are frequently used in the early stages of the drug discovery to explore how candidate molecules may interact with biological targets.

However, docking results are computational predictions and generally require complementary computational or experimental validation.

Molecular dynamics simulations

The molecular dynamics simulations (MD) use numerical methods to model the movement of atoms over time.

Unlike a static structural model, molecular dynamics can provide information on the flexibility of proteins and their conformational changes.

Applications include :

Studying protein stability
Studying conformational changes
Analysing protein-ligand interactions
Characterising the dynamics of binding sites
Studying protein-protein interactions
Exploring the effects of mutations
Evaluating molecular stability under different conditions

MD simulations thus provide a dynamic perspective of molecular systems that complements experimentally determined structures.

Homology modelling

The homology modelling, also known as comparative modelling, involves predicting the three-dimensional structure of a protein based on the experimentally determined or computationally predicted structure of a related protein.

The general process includes:

Identification of an appropriate structural model
Sequence alignment
Generation of the structural model
Model refinement
Structural quality assessment

This approach can be particularly useful when experimental structural information is not available for the protein under study.

Cryo-EM and computational structural reconstruction

The cryo-electron microscopy (cryo-EM) has become an important experimental technique for determining the structure of proteins and large molecular complexes.

Computational analysis is an essential component of cryo-EM workflows. Image processing and reconstruction algorithms are used to transform large collections of electron microscopy images into three-dimensional structural information.

Computational cryo-EM may notably include:

Particle detection
Image classification
Alignment
Three-dimensional reconstruction
The analysis of density maps
The fitting of atomic models
Structural refinement

The combination of cryo-EM and computational methods allows researchers to study increasingly complex molecular assemblies.

Analysis of protein-ligand interactions

Understanding how proteins interact with small molecules is essential in structural biology and pharmaceutical research.

Computational approaches can study :

Binding pockets
Hydrogen bonds
Hydrophobic interactions
Electrostatic interactions
Molecular contacts
Binding orientations
Structural changes after ligand binding

These analyses can help researchers formulate hypotheses about molecular recognition and guide subsequent experimental studies.

Prediction of domain architecture

Proteins frequently contain multiple structural or functional domains. Identifying these regions can provide important information about the function and evolution of proteins.

Computational analysis of domains can help identify :

Conserved domains
Functional motifs
Catalytic regions
Interaction domains
Repeated structural elements
Conserved regions throughout evolution

The combination of sequence analysis and structural information allows for a more comprehensive understanding of protein architecture.

Protein engineering and design

The computational structural biology is increasingly associated with protein engineering and synthetic biology.

Researchers can use computational approaches to study how modifications to amino acid sequences can influence :

Protein stability
Enzymatic activity
Binding affinity
Specificity
Solubility
Structural properties

Machine learning models can help identify promising protein variants, which can then be experimentally tested.

This creates an iterative relationship between computational prediction and laboratory experimentation.

Artificial intelligence in structural biology

Artificial intelligence has significantly expanded the computational approaches used in structural biology.

Machine learning and deep learning methods can be applied to :

The prediction of protein structures
The modelling of protein complexes
The analysis of molecular interactions
The analysis of protein sequences
The prediction of protein function
The prediction of mutation effects
Protein design
Structural classification

AI can process large sets of biological data and identify patterns that are difficult to detect using traditional computational approaches.

Protein structure and drug discovery

Structural information is particularly useful in the modern drug discovery.

Computational structural biology can contribute to several stages of the research process, including:

Target identification → Structural analysis → Binding site characterization → Molecular docking → Candidate prioritisation → Molecular simulation → Experimental validation

Structural models can help researchers study potential interactions between therapeutic candidates and biological targets.

When combined with genomics, transcriptomics, proteomics, and metabolomics, structural information can also contribute to broader strategies for multi-omic based drug discovery.

Integration of structural biology with multi-omics

Structural biology can be integrated with other disciplines of computational biology to create a more comprehensive view of molecular systems.

For example:

Genomics provides information on DNA sequences and genetic variations.
Transcriptomics describes gene expression.
Proteomics characterises proteins and their abundance.
Metabolomics studies small biological molecules.
Structural biology provides information on molecular architecture.
Computational modelling links these datasets through quantitative analyses.

This integration can help researchers move from biological sequences and molecular measurements to functional and mechanistic interpretations.

AI-assisted protein design

One of the emerging areas of structural biology is the design of proteins assisted by artificial intelligence.

Instead of being limited to predicting the structure of naturally occurring proteins, computational models can increasingly be used to explore new sequences and protein structures with desired properties.

Potential applications include:

Enzyme engineering
Development of therapeutic proteins
Antibody engineering
Development of biomaterials
Design of biosensors
Industrial biotechnology
Synthetic biology

Designs generated or selected by AI still require experimental testing, as computational predictions do not automatically demonstrate biological activity or safety.

From protein sequence to structural discovery

The integration of sequence analysis, structural databases, molecular simulations, and artificial intelligence creates increasingly interconnected computational workflows.

A simplified research pipeline can be represented as follows:

Protein sequence → Structural prediction → Structural analysis → Molecular interaction modelling → AI-assisted design → Experimental validation

This workflow illustrates how computational structural biology links molecular information to biological hypotheses that can be experimentally tested.

Future perspectives

Future developments in structural biology should increasingly combine:

Artificial intelligence
Fundamental protein models
Molecular simulations
Structural databases
Cryo-EM
Multi-omic data
Protein engineering
Generative computational design

The integration of these technologies creates new opportunities to understand protein function, molecular interactions, disease mechanisms, biotechnology, and therapeutic development.

The computational structural biology thus represents an important intersection between molecular biology, computational sciences, artificial intelligence, and protein engineering.

Artificial intelligence in biology

The artificial intelligence and machine learning are increasingly integrated into biological research to identify patterns within complex datasets and support computational analysis.

The applications of AI in computational biology include:

Disease prediction models
Prediction of interactions between drugs and biological targets
Prediction of protein structure
Image-based biological analysis
Interpretation of scientific data
Discovery of biomarkers
Genome annotation
Integration of multi-omic data
Predictive modelling

Deep learning architectures such as convolutional neural networks (CNNs), transformers, recurrent neural networks (RNNs) and graph neural networks (GNNs) are increasingly used to analyse biological data.

Large language models and AI systems can also contribute to the exploration of scientific literature, the organisation of biological information, the development of computational workflows, programming, and research-oriented data analysis.

Intelligent systems biology

The systems biology aims to understand how biological components dynamically interact within complex cellular networks.

Rather than studying genes or proteins individually, systems biology examines interconnected biological pathways, including :

Gene regulatory networks
Protein-protein interaction networks
Metabolic pathways
Signalling cascades
Cell communication networks
The dynamics of immune responses

The computational systems biology uses mathematical modelling, network analysis, simulation, and machine learning to study biological behaviour under different environmental and pathological conditions.

The integration of artificial intelligence into systems biology creates new opportunities to analyse complex biological networks, integrate multi-omic datasets, identify relationships between molecular components, and generate computational hypotheses that can be studied further.

From single-cell data to scientific discovery

The combination of single-cell sequencing, spatial transcriptomics, multi-omics, bioinformatics, artificial intelligence, and systems biology offers new approaches to study biological systems at high resolution.

Single-cell datasets can be integrated with computational methods and AI-assisted tools to explore cellular heterogeneity, molecular interactions, biological pathways, and relationships between different layers of biological data.

This interdisciplinary approach links experimental biology to computational analysis and emerging smart technologies, creating new possibilities for transforming complex biological data into scientific knowledge.

Computational single-cell biology in research

The computational single-cell biology combines high-throughput sequencing, bioinformatics, statistics, artificial intelligence, and computational modelling to study biological processes at the scale of individual cells.

The increasing availability of data from the single-cell RNA sequencing, spatial transcriptomics, single-cell epigenomics, single-cell proteomics, and multi-omic approaches allows researchers to characterise cell populations with unprecedented molecular resolution.

Computational approaches are used to process large sets of biological data, identify cell populations, characterise molecular states, reconstruct cell trajectories, and study interactions between cells and their microenvironment.

Precision medicine

The precision medicine aims to improve the prevention, diagnosis, and treatment of diseases by taking into account the genetic, molecular, cellular, and clinical characteristics unique to each individual.

Computational biology contributes to precision medicine by integrating genomic, transcriptomic, proteomic, and clinical information to identify molecular profiles associated with diseases and therapeutic response.

Computational approaches can contribute to :

Personalised therapeutic strategies
Pharmacogenomic analysis
Mutation profiling in cancers
The discovery of biomarkers
Biomarker-based diagnosis
The classification of disease subtypes
Predictive modelling of diseases
Analysis of treatment response
Patient stratification
Identification of molecular targets

Single-cell analysis in precision medicine

Single-cell technologies provide information that can be masked when tissues are analysed as a mixture of many cell types.

The single-cell RNA sequencing allows for the identification of cell populations, rare cell states, and molecular differences between individual cells. In cancer research, for example, computational single-cell analysis can help characterise tumour cells, immune populations, stromal cells, and cell states associated with tumour progression or treatment response.

The spatial transcriptomics can complement single-cell analysis by providing information on the location of cell populations with distinct molecular profiles within a tissue.

The integration of single-cell and spatial data can thus provide a more detailed view of tissue organisation and cellular interactions.

Computational genomics and pharmacogenomics

Genomic analysis can help identify genetic variants associated with disease susceptibility, drug metabolism, and treatment responses.

Computational pipelines can be used for :

The identification of variants
The annotation of variants
The prioritisation of genes
Pharmacogenomic analysis
The analysis of molecular pathways
The study of genotype-phenotype relationships

These approaches can help researchers study how genetic differences may influence biological processes and therapeutic responses.

AI-assisted interpretation of clinical data

The artificial intelligence and machine learning are increasingly being studied for the analysis of complex biomedical datasets.

AI-assisted approaches can contribute to :

Pattern recognition
Molecular classification
Image analysis
Biomarker prediction
The integration of multi-omic data
Risk modelling
The organisation of clinical data
The interpretation based on scientific literature

The large language models can also assist researchers in the search for scientific information, data organisation, the development of computational workflows, and the interpretation of complex biomedical concepts.

However, analyses generated by AI require appropriate validation, quality control, and human expertise before any use in clinical decision-making.

Multi-omic integration

Precision medicine increasingly relies on the integration of multiple molecular layers rather than a single type of biological measurement.

Multi-omic computational approaches can combine :

Genomics → Transcriptomics → Proteomics → Metabolomics → Epigenomics → Spatial omics

The integration of these data can provide complementary insights into genetic variations, gene expression, protein activity, metabolic states, and tissue organisation.

Machine learning methods and statistical approaches can help identify relationships between these different molecular layers and generate hypotheses regarding disease mechanisms and therapeutic targets.

Applications in cancer research

The cancer is one of the main areas where computational single-cell biology and precision medicine are actively studied.

Single-cell and spatial technologies can contribute to characterising :

Tumour heterogeneity
States of cancer cells
Populations of immune cells
Tumour microenvironment
Cellular interactions
Treatment-resistant populations
Molecular biomarkers
Potential therapeutic targets

Computational analysis can reveal cellular populations that are difficult to detect with conventional bulk sequencing approaches.

Research on rare diseases

In the field of rare diseases, computational genomics and transcriptomics can help researchers study genetic variants and molecular abnormalities that may contribute to pathological phenotypes.

The combination of sequencing data, computational annotation, gene expression analysis, and biological databases can aid in the prioritisation of candidate genes and variants for further study.

Single-cell approaches can provide additional insights when disease mechanisms involve specific cellular populations or states.

From computational data to precision medicine

The integration of single-cell biology, genomics, spatial technologies, multi-omics, artificial intelligence, and computational modelling enables the development of increasingly detailed approaches to study human diseases.

Rather than relying on a single molecular measure, computational precision medicine can integrate multiple levels of biological information in order to study individual variations, disease mechanisms, biomarkers, and potential therapeutic responses.

These approaches mainly constitute research and analysis tools. Their application to clinical practice requires rigorous validation, appropriate clinical data, regulatory oversight, and their integration into established medical decision-making processes.

Emerging fields

Synthetic biology

Synthetic biology combines principles from biology, engineering, computer science, and computational modelling to design, construct, and optimise biological systems with defined functions. Rather than being limited to observing natural biological processes, synthetic biology seeks to understand and redesign biological components, biological pathways, and cellular systems.

Computational biology has become an important component of modern synthetic biology, as biological design involves increasingly large datasets as well as complex interactions between genes, proteins, metabolic pathways, and cellular environments.

Computational approaches can contribute to :

The design of genetic circuits
The analysis of séquences génétiques
L’optimisation des voies métaboliques
L’ingénierie de génomes synthétiques
La prédiction des voies biosynthétiques
L’ingénierie des protéines et des enzymes
La modélisation de la bioproduction
La conception de stratégies d’édition génomique basées sur CRISPR
L’intégration de données multiomiques
La conception de cellules microbiennes usines pour la production biologique

Conception computationnelle des systèmes biologiques

La biologie synthétique moderne suit de plus en plus un cycle Design–Build–Test–Learn (DBTL), c’est-à-dire Concevoir–Construire–Tester–Apprendre. Les modèles computationnels peuvent être utilisés au cours de l’étape de conception afin d’explorer différentes constructions génétiques, voies métaboliques et configurations biologiques avant de procéder aux essais expérimentaux.

Les chercheurs peuvent utiliser des bases de données génomiques, des modèles métaboliques, l’apprentissage automatique et des outils d’analyse des voies biologiques pour évaluer les conceptions potentielles et prioriser les candidats à valider en laboratoire.

Cette approche computationnelle peut réduire le nombre de conceptions expérimentales à tester et permettre aux chercheurs d’explorer des espaces de conception biologique difficiles à étudier manuellement.

Ingénierie métabolique

L’metabolic engineering uses genetic and computational approaches to modify cellular metabolism to produce value-added compounds.

Computational models can help researchers study:

Metabolic fluxes
Enzymatic activity
Bottlenecks in metabolic pathways
The availability of precursors
Cofactor requirements
Competing metabolic pathways
The allocation of cellular resources

Genome-scale metabolic models and machine learning approaches can thus contribute to the design and optimisation of microbial factory cells intended for bioproduction. Recent computational frameworks increasingly combine information from molecular, biological pathways, cellular, and process levels.

Artificial intelligence in synthetic biology

The artificial intelligence is increasingly integrated into synthetic biology. Machine learning and deep learning approaches can analyse vast biological datasets and contribute to sequence design, protein engineering, biological pathway prediction, and metabolic optimisation.

Recent approaches to biofoundries based on AI combine machine learning, generative AI, automation, and high-throughput experimentation to accelerate the Design–Build–Test–Learn.

The large language models are also studied for applications in synthetic biology and bioproduction. Recent work describes applications related to knowledge extraction, metabolic modelling, experimental design, and AI-assisted bioproduction workflows.

Design of biosynthetic pathways

An important application of computational synthetic biology concerns the design of biosynthetic pathways that enable the production of specific molecules.

Computational methods can combine information on :

Chemical compounds
Enzymes
Biological reactions
Metabolic pathways
Genomic databases
Enzymatic functions

Algorithms for retrosynthesis and biological databases can be used to identify potential pathways to convert available substrates into desired products. The computational design of biological pathways can thus help researchers evaluate different biosynthetic strategies before their experimental implementation.

CRISPR and genome engineering

Technologies based on CRISPR provide powerful tools to modify biological systems. When combined with computational analysis, CRISPR approaches can be used to study gene functions, modify metabolic pathways, and optimise genetically engineered organisms.

Computational tools can contribute to the design of guides, the selection of targets, the analysis of the genome, the interpretation of screening data, and the identification of genetic targets for metabolic engineering.

High-throughput CRISPR approaches also allow for the simultaneous study of multiple genetic modifications, thus contributing to the development of more complex microbial factory cells.

Applications

Synthetic biology and computational engineering are studied in many fields, including:

The production of biofuels
Pharmaceutical bioproduction
Biologically engineered therapies
Sustainable chemicals
The production of biomaterials
Industrial biotechnology
Enzyme engineering
Microbial factory cells
Agricultural biotechnology
Environmental biotechnology

The combination of synthetic biology, computational modelling, AI, and automation directs biological engineering towards increasingly data-driven and design-focused workflows.

Computational immunology

Computational immunology is an interdisciplinary field that combines immunology, bioinformatics, statistics, mathematical modelling, and artificial intelligence to study how the immune system responds to pathogens, abnormal cells, vaccines, and therapeutic interventions.

The immune system involves extremely complex interactions between immune cells, receptors, antibodies, cytokines, signalling pathways, and molecular targets. Computational approaches allow for the analysis of these interactions from genomic, transcriptomic, proteomic, and single-cell data on a large scale.

Modern computational immunology integrates data from technologies such as single-cell RNA sequencing, immune repertoire sequencing, spatial transcriptomics, proteomics, and high-throughput sequencing, in order to characterise immune responses with molecular and cellular resolution.

Computational immunology supports a wide range of research applications, including:

Vaccine design
Analysis of immune repertoires
Modelling host-pathogen interactions
Research on cancer immunotherapy
Analysis and prediction of T cell receptors
Analysis of B cell receptors
Antibody engineering
Discovery of immune biomarkers
Analysis of cytokines and signalling pathways
Modelling of immunological diseases
Single-cell immune profiling
The integration of multi-omic data

Single-cell immunology

Single-cell technologies have significantly expanded the ability to study immune cell populations individually.

The single-cell RNA sequencing can be used to characterise different types of immune cells and study changes in their transcriptional state during an infection, inflammation, cancer, or therapeutic treatment.

Computational analysis can help identify :

T lymphocytes
B lymphocytes
Natural killer (NK) cells
Macrophages
Dendritic cells
Monocytes
Regulatory immune populations
Rare or previously uncharacterised cellular states

Single-cell analysis can also reveal thecellular heterogeneity and help researchers study how immune populations evolve during the progression of a disease or treatment.

Analysis of immune repertoires

The adaptive immune system generates extremely diverse populations of T and B lymphocyte receptors.

Computational analysis of immune repertoires uses sequencing data to study the diversity, composition, and dynamics of these receptor populations.

Researchers can analyse :

The sequences of T lymphocyte receptors
The sequences of B lymphocyte receptors
Clonal expansion
Receptor diversity
V(D)J recombination
Antigen-associated immune responses
Clonal relationships between immune cells

The combination of immune repertoire sequencing with single-cell transcriptomics can provide information on both the identity of receptors and the cellular state.

Vaccine research

Computational approaches can support vaccine research by helping researchers study the genomes of pathogens, antigenic candidates, immune responses, and potential molecular targets.

Bioinformatics can be used for :

The analysis of pathogen genomes
The identification of antigens
The prediction of epitopes
The comparison of sequences
The modelling of immune responses
The prioritisation of vaccine candidates

Machine learning approaches can help researchers identify trends in large datasets and prioritise candidates for experimental validation.

Computational predictions remain complementary to laboratory experiments and immunological validation.

Cancer immunology and immunotherapy

Computational immunology plays an important role in cancer research, as tumours dynamically interact with immune cells within the tumour microenvironment.

Single-cell and spatial technologies can be used to characterise interactions between :

Tumour cells
T lymphocytes
B lymphocytes
Macrophages
Natural killer cells
Dendritic cells
Stromal cells

Computational analysis can help study the states of immune cells, tumour heterogeneity, cellular communication, and molecular signatures associated with treatment responses.

These approaches are studied in the context of immunotherapies such as the immune checkpoint inhibitors and other personalised therapeutic strategies.

Host-pathogen interactions

Computational models can also be used to study the interactions between pathogens and the host's immune system.

By combining pathogen sequencing with the host's transcriptomic and immunological data, researchers can study how infections modify cellular states and signalling pathways.

Applications include :

Analysis of the genomes of pathogens
Profiling the host's response
Analysis of immune pathways
Identification of biomarkers associated with infections
Host-pathogen interaction networks
Modelling disease progression

Single-cell approaches can provide additional resolution by revealing how different cell populations respond to the same infectious stimulus.

Artificial intelligence in computational immunology

Artificial intelligence and machine learning are increasingly being studied for the analysis of complex immunological data.

AI-assisted approaches can contribute to :

Classification of immune cells
The prediction of epitopes
Analysis of T cell receptors
The analysis of antibody sequences
The discovery of biomarkers
The prediction of immune responses
The modelling of protein-antibody interactions
The integration of multi-omic data
The analysis of cellular communication

Deep learning, the graph neural networks, the transformers and other machine learning approaches can be applied to biological sequences, molecular structures, cellular networks, and high-dimensional single-cell datasets.

The large language models can also assist researchers in exploring scientific literature, organising biological knowledge, developing computational workflows, and interpreting complex immunological concepts.

Multiomics and systems immunology

Modern computational immunology increasingly integrates multiple levels of biological data.

For example:

Genomics → Transcriptomics → Proteomics → Immune repertoire → Spatial omics → Clinical data

The integration of these datasets can provide a more comprehensive view of immune responses and help researchers study the relationships between genetic variation, cellular states, molecular signalling, and tissue organisation.

The systems immunology uses computational modelling and network analysis to study the immune system as an interconnected biological system rather than as a set of isolated molecular components.

Future perspectives

The combination of séquençage unicellulaire, de l’omique spatiale, de l’analyse des répertoires immunitaires, de la multiomique, de l’intelligence artificielle et de la modélisation computationnelle crée de nouvelles approches pour étudier la biologie immunitaire.

Les recherches futures devraient de plus en plus relier les mesures cellulaires à haute résolution à des modèles computationnels capables d’intégrer plusieurs modalités biologiques. Ces approches pourraient contribuer à une meilleure compréhension des maladies infectieuses, du cancer, des maladies auto-immunes, des réponses vaccinales et des immunothérapies personnalisées.

Les prédictions computationnelles doivent rester soumises à une validation expérimentale, statistique et clinique appropriée avant leur traduction dans des applications biologiques ou médicales.

Défis scientifiques

Malgré des avancées majeures, la biologie computationnelle reste confrontée à plusieurs défis :

La complexité des données biologiques
La standardisation des ensembles de données
La reproductibilité des données
La capacité à mettre à l’échelle les pipelines computationnels
L’intégration de données omiques hétérogènes
L’interprétabilité des modèles d’IA
La gestion éthique des données génomiques
Le coût computationnel des simulations à grande échelle

La résolution de ces défis nécessite une collaboration interdisciplinaire entre biologistes, informaticiens, mathématiciens, cliniciens et ingénieurs.

Future perspectives

L’avenir de la biologie computationnelle est porté par l’artificial intelligence, automation, cloud computing and the generation of large-scale biological data.

Future innovations may include:

Digital modelling of cells
The generation of therapeutic molecules by AI
Predictive simulations at the whole organism scale
Real-time interpretation of clinical genomic data
Personalised regenerative medicine
Autonomous laboratory systems
Applications of quantum computing to molecular simulation

As biological datasets continue to grow exponentially, computational biology will remain a central element of scientific discovery, biomedical innovation and next-generation healthcare.

Why computational biology is important

Computational biology transforms our understanding of life at the molecular level. It enables scientists to decode genomes, model biological systems, predict the behaviour of molecules, and accelerate medical innovation.

By integrating experimental biology with computational intelligence, researchers can explore biological complexity more effectively than ever.

The convergence of biologie, de la science des données et de l’intelligence artificielle ouvre une nouvelle ère pour les biotechnologies et la médecine de précision — une ère dans laquelle la biologie computationnelle constitue l’un des fondements des sciences du vivant modernes.